vs
Side-by-side financial comparison of GLAUKOS Corp (GKOS) and WORK Medical Technology Group LTD (WOK). Click either name above to swap in a different company.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
GKOS
WOK
| Q4 25 | $143.1M | — | ||
| Q3 25 | $133.5M | — | ||
| Q2 25 | $124.1M | — | ||
| Q1 25 | $106.7M | — | ||
| Q4 24 | $105.5M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $95.7M | — | ||
| Q1 24 | $85.6M | — |
Net ProfitGKOSWOK
| Q4 25 | $-133.7M | — | ||
| Q3 25 | $-16.2M | — | ||
| Q2 25 | $-19.7M | — | ||
| Q1 25 | $-18.1M | — | ||
| Q4 24 | $-33.6M | — | ||
| Q3 24 | $-21.4M | — | ||
| Q2 24 | $-50.5M | — | ||
| Q1 24 | $-40.8M | — |
Gross MarginGKOSWOK
| Q4 25 | -1.1% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 77.2% | — | ||
| Q4 24 | 72.9% | — | ||
| Q3 24 | 76.6% | — | ||
| Q2 24 | 76.4% | — | ||
| Q1 24 | 76.3% | — |
Operating MarginGKOSWOK
| Q4 25 | -97.7% | — | ||
| Q3 25 | -12.3% | — | ||
| Q2 25 | -18.3% | — | ||
| Q1 25 | -19.4% | — | ||
| Q4 24 | -27.2% | — | ||
| Q3 24 | -25.5% | — | ||
| Q2 24 | -31.3% | — | ||
| Q1 24 | -45.6% | — |
Net MarginGKOSWOK
| Q4 25 | -93.4% | — | ||
| Q3 25 | -12.2% | — | ||
| Q2 25 | -15.8% | — | ||
| Q1 25 | -17.0% | — | ||
| Q4 24 | -31.8% | — | ||
| Q3 24 | -22.1% | — | ||
| Q2 24 | -52.8% | — | ||
| Q1 24 | -47.7% | — |
EPS (diluted)GKOSWOK
| Q4 25 | $-2.34 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | $-0.56 | — | ||
| Q3 24 | $-0.39 | — | ||
| Q2 24 | $-1.00 | — | ||
| Q1 24 | $-0.82 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
